DOI: http://dx.doi.org/10.22516/25007440.82

Métodos diagnósticos en hipertensión portal

Juan Pareja, Juan Restrepo

Resumen


La hipertensión portal en el curso natural de las enfermedades hepáticas es una de las complicaciones más frecuentes resultado del aumento de la resistencia vascular hepática que determina el desarrollo de otros sucesos responsables de la mayor mortalidad en pacientes con hepatopatías. En consecuencia, el conocimiento de la fisiopatología de la hipertensión portal y de sus causas representa un factor importante para su adecuado manejo y el de las demás complicaciones relacionadas. Es así como se cuentan con métodos diagnósticos de diferentes tipos para la detección temprana y adecuada de dicha entidad; lo cual, además, corresponde al objetivo de la presente revisión: dar una mirada a los métodos diagnósticos utilizados para la detección de hipertensión portal, disponibles en la actualidad. 


Palabras clave


Cirrosis; hipertensión portal; gradiente de presión venosa hepática; elastografía; ARFI; Resonancia magnética; biomarcadores

Texto completo:

PDF

Referencias


Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7(2):141-55.

García Buey L, González Mateos F, Moreno-Otero R. Cirrosis hepática. Medicine - Programa de Formación Médica Continuada Acreditado. 2012;11(11):625-33.

Hu LS, George J, Wang JH. Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol. 2013;19(11):1707-17.

Sarin SK, Khanna R. Non-cirrhotic portal hypertension. Clin Liver Dis. 2014;18(2):451-76.

Carey W. Portal hypertension: diagnosis and management with particular reference to variceal hemorrhage. J Dig Dis. 2011;12(1):25-32.

Palaniyappan N, Aithal GP. Portal hypertension and ascites. Surgery (Oxford). 2011;29(12):640-6.

Iwakiri Y. Pathophysiology of portal hypertension. Clin Liver Dis. 2014;18(2):281-91.

Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749-61.

Bosch J, Abraldes JG, Fernandez M, Garcia-Pagan JC. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol. 53. England: 2010 European Association for the Study of the Liver. Published by Elsevier B.V; 2010. p. 558-67.

Kim MY, Baik SK, Lee SS. Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol. Korea South. 2010. p. 347-52.

Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol. 2014;61(4):912-24.

Sharma M, Rameshbabu CS. Collateral Pathways in portal hypertension.J Clin Exp Hepatol. 2012;2(4):338-52.

Thabut D, Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol. 53. England: 2010 European Association for the Study of the Liver. Published by Elsevier B.V; 2010. p. 976-80.

Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43(2 Suppl 1):S121-31.

Shi KQ, Fan YC, Pan ZZ, Lin XF, Liu WY, Chen YP, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013;33(1):62-71.

Merkel C, Montagnese S. Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis. 43. Netherlands: 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd; 2011. p. 762-7.

La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores- Arroyo A, Garcia-Pagan JC, et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology. 2010;51(6):2108-16.

Procopeţ B, Tantau M, Bureau C. Are there any alternative methods to hepatic venous pressure gradient in portal hypertension assessment? J Gastrointestin Liver Dis. 2013;22(1):73-8.

Augustin S, González A, Badia L, Millán L, Gelabert A, Romero A, et al. Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding. Hepatology. 2012;56(2):706-14.

Woolfson J, John P, Kamath B, Ng VL, Ling SC. Measurement of hepatic venous pressure gradient is feasible and safe in children. J Pediatr Gastroenterol Nutr. 2013;57(5):634-7.

Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol. 2011;54(4):650-9.

Şirli R, Sporea I, Bota S, Raţiu I. Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis. Med Ultrason. 2012;14(3):225-30.

Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther. 2008;28(9):1102-10.

Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol. 2011;55(5):1017-24.

Llop E, Berzigotti A, Reig M, Erice E, Reverter E, Seijo S, et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol. 2012;56(1):103-8.

Sánchez-Conde M, Miralles P, Bellón JM, Rincón D, Ramírez M, Gutiérrez I, et al. Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients. J Viral

Hepat. 2011;18(10):685-91.

Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol. 2011;25(2):291-303.

Hirsch S, Guo J, Reiter R, Schott E, Büning C, Somasundaram R, et al. Towards compression-sensitive magnetic resonance elastography of the liver: sensitivity of harmonic volumetric strain to portal hypertension. J Magn Reson Imaging. 2014;39(2):298-306.

Hirsch S, Guo J, Reiter R, Papazoglou S, Kroencke T, Braun J, et al. MR elastography of the liver and the spleen using a piezoelectric driver, single-shot wave-field acquisition, and multifrequency dual parameter reconstruction. Magn Reson Med. 2014;71(1):267-77.

Talwalkar JA, Yin M, Venkatesh S, Rossman PJ, Grimm RC, Manduca A, et al. Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol. 2009;193(1):122-7.

Nedredal GI, Yin M, McKenzie T, Lillegard J, Luebke- Wheeler J, Talwalkar J, et al. Portal hypertension correlates with splenic stiffness as measured with MR elastography. J Magn Reson Imaging. 2011;34(1):79-87.

Sun HY, Lee JM, Han JK, Choi BI. Usefulness of MR elastography for predicting esophageal varices in cirrhotic patients. J Magn Reson Imaging. 2014;39(3):559-66.

Ronot M, Lambert S, Elkrief L, Doblas S, Rautou P-E, Castera L, et al. Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol. 2014;24(6):1394-402.

Shin SU, Lee J-M, Yu MH, Yoon JH, Han JK, Choi B-I, et al. Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echoplanar imaging technique. Radiology. 2014;272(1):143-53.

Berzigotti A, Ashkenazi E, Reverter E, Abraldes JG, Bosch J. Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension. Dis Markers. 2011;31(3):129-38.

Gerstenmaier JF, Gibson RN. Ultrasound in chronic liver disease. Insights Imaging. 2014;5(4):441-55.

Furuichi Y, Moriyasu F, Taira J, Sugimoto K, Sano T, Ichimura S, et al. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol. 2013;48(9):1061-8.

Uchida H, Sakamoto S, Kobayashi M, Shigeta T, Matsunami M, Sasaki K, et al. The degree of spleen stiffness measured on acoustic radiation force impulse elastography predicts the severity of portal hypertension in patients with biliary atresia after portoenterostomy. J Pediatr Surg. 2015;50(4):559-64.

Han J-Y, Cho JH, Kwon HJ, Nam KJ. Predicting portal hypertension as assessed by acoustic radiation force impulse: correlations with the Doppler ultrasound. Br J Radiol. 2012;85(1016):e404-409.

Friedrich-Rust M, Rosenberg W, Parkes J, Herrmann E, Zeuzem S, Sarrazin C. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol. 2010;10:103.

Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenau M, Valla DC, et al. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther. 2007;26(3):359-68.

Poca M, Puente A, Graupera I, Villanueva C. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled. Dis Markers. 2011;31(3):147-54.

Buck M, Garcia-Tsao G, Groszmann RJ, Stalling C, Grace ND, Burroughs AK, et al. Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients. Hepatology. 2014;59(3):1052-9.

Hayashi H, Beppu T, Okabe H, Nitta H, Imai K, Doi K, et al. Combined measurements of serum bile acid level and splenic volume may be useful to noninvasively assess portal venous pressure. J Gastroenterol. 2012;47(12):1336-41.

Procopet B, Cristea VM, Robic MA, Grigorescu M, Agachi PS, Metivier S, et al. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension. Dig Liver Dis. 2015;47(5):411-6.

Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32-6.

Jansen C, Leeming DJ, Mandorfer M, Byrjalsen I, Schierwagen R, Schwabl P, et al. PRO-C3-levels in patients with HIV/ HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. PLoS ONE. 2014;9(9):e108544.

Hassan EM, Omran DA, El Beshlawey ML, Abdo M, El Askary A. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients? Gastroenterol Hepatol. 2014;37(2):58-65.

Stefanescu H, Procopet B. Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond. World J Gastroenterol. 2014;20(45):16811-9.

Stefanescu H, Radu C, Procopet B, Lupsor-Platon M, Habic A, Tantau M, et al. Non-invasive ménage à trois for the prediction of high-risk varices: stepwise algorithm using lok score, liver and spleen stiffness. Liver Int. febrero de 2015;35(2):317-25.


Métricas de artículo

Cargando métricas ...

Metrics powered by PLOS ALM

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2017 Revista Colombiana de Gastroenterología

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

ISSN versión impresa 0120-9957

ISSN versión en línea 2500-7440

  Licencia de Creative Commons
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.